new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
As the technology revolution rages on, the age-old battle rears its head: old vs. new, computers vs....
Ever wonder what goes on behind the scenes in R&D at QIAGEN Digital Insights? Our team of expert...
Explore QIAGEN CLC Genomics Workbench Premium Food and feed safety is a main concern for food aut...
Basic pathway analysis has several limitations that can slow down research progress and hinder insig...
Improved performance, faster data download, and 340,000+ mutation entries The Fall 2021 Release of ...
Manual curation in the age of automation: COSMIC’s gold standard database
Sample to Insight use cases for biomarker discovery from the QIAGEN Digital Insights team
The use of NGS in food and feed safety
QIAGEN IPA Analysis Match now includes over 100,000 analyses to help advance your research
Now Available: HGMD Professional 2021.3
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients